Hlavaty et al developed models for predicting outcome of infliximab therapy in a patient with Crohn's disease (CD). The authors are from University Hospital Gasthuisberg in Leuven, Belgium, and University Hospital Bratislava in Slovakia.
To read more or access our algorithms and calculators, please log in or register.
